Rumi Viro

Rumi Viro’s mission is to mitigate the impact viruses have on human health, via its human stem cell technology that uses state-of-the-art imaging and analytical tools to inexpensively and effectively identify antiviral treatments for human infectious diseases.
For inquiries, please contact us at

Edwin Rosado-Olivieri

Black and white profile photo of Edwin Rosado Olivieri

Edwin Rosado-Olivieri, Ph.D., Vice President


Dr. Rosado-Olivieri is the Vice President of RumiViro and directs the technological developments for viral infectious diseases at Rumi Scientific. He obtained his doctoral degree from Harvard Medical School, under the mentoring of Dr. Douglas Melton, after completing his bachelor’s degree in Cell and Molecular Biology from the University of Puerto, Río Piedras campus. As a postdoctoral scholar, he joined the laboratory of RumiViro’s founder Dr. Ali Brivanlou at The Rockefeller University, where he developed an innovative stem cell-based platform to track infection by SARS-CoV-2 and identify therapeutics for COVID-19, in collaboration with the laboratory of Dr. Charles Rice. This platform is now used at RumiViro to develop antiviral therapies. Among his awards, he is the recipient of a Merit Award from the International Society for Stem Cell Research in 2019, Harvard Blavatnik Biomedical Accelerator in 2019, Harvard Distinction in Teaching Award in 2016, UPR Distinction in Research Award in 2015, and the NFS GRFP fellowship in 2014.

I would like to learn about Rumi Viro’s novel discoveries to treat genetic diseases.